Funds holding Yabao Pharmaceutical Group Co Ltd
ISIN CNE000001CM5 · China · LEI 65560071PKRS4UHMVU53
- Fund holders
- 6
- Of which ETFs
- 0 6 other funds
- Value held
- 3.6M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Acadian Emerging Markets Portfolio ADVISORS' INNER CIRCLE FUND | 1,393,800 | 1.3M $ | 0.08 % | as of Jul 31, 2026 ↗ |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 874,000 | 838K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Strategic Advisers Emerging Markets Fund Fidelity Rutland Square Trust II | 683,000 | 642K $ | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 631,483 | 605.5K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 186,100 | 178.4K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 38,900 | 37.3K $ | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Acadian Emerging Markets Portfolio ADVISORS' INNER CIRCLE FUND | 0.08 % | as of Jul 31, 2026 ↗ |
| Strategic Advisers Emerging Markets Fund Fidelity Rutland Square Trust II | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 0.00 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 6 | 0 | 3,807,283 | +36.2 % |
| 2026Q2 | 6 | +2 | 2,794,883 | +61.5 % |
| 2026Q1 | 4 | 0 | 1,730,483 | -13.1 % |
| 2025Q4 | 4 | -1 | 1,992,483 | -27.4 % |
| 2025Q3 | 5 | +1 | 2,743,483 | +27.5 % |
| 2025Q2 | 4 | 0 | 2,151,983 | -4.2 % |
| 2025Q1 | 4 | 0 | 2,247,183 | -10.9 % |
| 2024Q4 | 4 | 0 | 2,522,583 | +16.4 % |
| 2024Q3 | 4 | 0 | 2,166,283 | 0.0 % |
| 2024Q2 | 4 | 0 | 2,166,283 | +56.4 % |
| 2023Q4 | 4 | 1,385,383 |
Cite this page
Titelia. "Funds holding Yabao Pharmaceutical Group Co Ltd". https://titelia.com/en/stocks/yabao-pharmaceutical-group-co-ltd-CNE000001CM5